Yibing Lu
Impact in
-
- Diabetes Treatment and Management
- Hormonal Regulation and Hypertension
- Geriatrics and Gerontology top 5%
- Sirtuins and Resveratrol in Medicine
Papers in
-
- Diabetes Treatment and Management 8
- Hormonal Regulation and Hypertension 2
- Thyroid Cancer Diagnosis and Treatment 2
- Diabetes Management and Research 2
-
- Cancer-related molecular mechanisms research 6
- MicroRNA in disease regulation 3
- Co-authors
- Dafa Ding (12 shared papers)Xiaolong Ye (6 shared papers)Heng Miao (5 shared papers)Jiarong Xu (4 shared papers)You Na (4 shared papers)Qun Zhu (3 shared papers)Qiang You (4 shared papers)Shanshan Huang (3 shared papers)
- Journals
- Diabetes Obesity and Metabolism (6 papers)Oncology Reports (2 papers)Diabetes Care (2 papers)Frontiers in Microbiology (1 paper)Molecular and Cellular Endocrinology (1 paper)
- Partner nations
- ChinaUnited StatesDenmark
In The Last Decade
Yibing Lu
38 papers receiving 1.1k citations
Yibing Lu's Hit Papers
Peers
Comparison fields: 5 of 87
- Endocrinology, Diabetes and Metabolism 336
- Geriatrics and Gerontology 63
- Nephrology 98
- Cancer Research 148
- Physiology 31
Countries citing papers authored by Yibing Lu
This map shows the geographic impact of Yibing Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yibing Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yibing Lu more than expected).
Fields of papers citing papers by Yibing Lu
This network shows the impact of papers produced by Yibing Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yibing Lu. The network helps show where Yibing Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Yibing Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium–Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis Hit paper breakdown → | 2022 | 167 |
| 2 | 2017 | 95 | |
| 3 | 2010 | 93 | |
| 4 | 2015 | 89 | |
| 5 | Tirzepatide for Weight Reduction in Chinese Adults With Obesity Hit paper breakdown → | 2024 | 86 |
| 6 | 2023 | 61 | |
| 7 | 2018 | 44 | |
| 8 | 2018 | 41 | |
| 9 | 2020 | 39 | |
| 10 | 2012 | 36 | |
| 11 | 2016 | 32 | |
| 12 | 2018 | 31 | |
| 13 | 2013 | 30 | |
| 14 | 2022 | 30 | |
| 15 | MicroRNA-134-5p promotes high glucose-induced podocyte apoptosis by targeting bcl-2. | 2018 | 24 |
| 16 | 2022 | 24 | |
| 17 | 2019 | 19 | |
| 18 | 2018 | 19 | |
| 19 | 2023 | 17 | |
| 20 | 2021 | 17 |
About Yibing Lu
Yibing Lu is a scholar working on Endocrinology, Diabetes and Metabolism, Cancer Research, Geriatrics and Gerontology, Epidemiology and Pulmonary and Respiratory Medicine, having authored 41 papers that have together received 1.1k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (8 papers), Cancer-related molecular mechanisms research (6 papers), MicroRNA in disease regulation (3 papers), Hormonal Regulation and Hypertension (2 papers), Sirtuins and Resveratrol in Medicine (2 papers), Thyroid Cancer Diagnosis and Treatment (2 papers), Autophagy in Disease and Therapy (2 papers) and Diabetes Management and Research (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (336 citations), Geriatrics and Gerontology (63 citations), Nephrology (98 citations), Cancer Research (148 citations) and Physiology (31 citations). Yibing Lu has collaborated with scholars based in China, United States and Denmark. Frequent co-authors include Dafa Ding, Xiaolong Ye, Heng Miao, Jiarong Xu, You Na, Qun Zhu, Qiang You, Shanshan Huang, Bin Song and Ming Rong Liu. Their work appears in journals such as Diabetes Obesity and Metabolism, Oncology Reports, Diabetes Care, Frontiers in Microbiology and Molecular and Cellular Endocrinology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.